(function(){var loadHandler=window['sl_{B169E353-1691-4AFC-B51D-F07AF60FC333}'];loadHandler&&loadHandler(7, '<div id="spr0_5878612b"><div id="spr1_5878612b" class="kern slide"><img id="img4_5878612b" src="data/img1.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_5878612b" class="kern slide"><img id="img0_5878612b" src="data/img3.png" width="721.48" height="100.8" alt="" style="left:-1.48px;"/><div id="svg1_5878612b" style="left:-1.48px;top:99.523px;"><svg width="722" height="4" viewBox="0 0 722 4"><path fill="#c76c02" d="M0,0 h721.48 v3.6 h-721.48 Z"/></svg></div><div id="svg2_5878612b" style="left:-1.48px;top:0.523px;"><svg width="722" height="4" viewBox="0 0 722 4"><path fill="#2e3546" d="M0,0 h721.48 v3.6 h-721.48 Z"/></svg></div><img id="img1_5878612b" src="data/img8.png" width="721.48" height="43.101" alt="" style="top:496.899px;"/><div id="spr3_5878612b" style="left:657.715px;top:499.855px;"><img id="img2_5878612b" src="data/img9.png" width="56" height="36" alt="CHRC logo_with text.psd" style="left:-0.105px;top:-0.177px;"/></div><div id="spr4_5878612b" style="left:-0.74px;top:0.523px;"><div style="width:0px;"><span id="txt0_5878612b" class="relpos" style="left:137.535px;top:5.272px;">G</span><span id="txt1_5878612b" class="relpos" data-width="119.777344" style="left:137.53px;top:5.272px;">uideline </span><span id="txt2_5878612b" class="relpos" style="left:137.525px;top:5.272px;">O</span><span id="txt3_5878612b" class="relpos" data-width="106.628906" style="left:137.52px;top:5.272px;">riented </span><span id="txt4_5878612b" class="relpos" style="left:137.515px;top:5.272px;">A</span><span id="txt5_5878612b" class="relpos" data-width="152.525391" style="left:137.51px;top:5.272px;">pproach to</span></div><div style="width:0px;"><span id="txt6_5878612b" class="relpos" style="left:128.75px;top:48.472px;">L</span><span id="txt7_5878612b" class="relpos" data-width="444.533203" style="left:128.745px;top:48.472px;">ipid lowering in Canada (GOAL)</span></div></div><div id="spr5_5878612b" style="left:4.821px;top:118.893px;"><div style="width:0px;"><span id="txt8_5878612b" class="nokern relpos" style="left:7.2px;top:5.005px;"></span><span id="txt9_5878612b" class="relpos" data-width="621.984375" style="left:25.965px;top:4.592px;">The GOAL Program  is an ongoing real-world designed and coordinated by the Canadian Heart</span></div><div style="width:0px;"><span id="txt10_5878612b" data-width="111.568359" style="left:34.2px;top:26.192px;">Research Centre</span></div></div><div id="spr6_5878612b" style="left:4.821px;top:118.893px;"><div style="width:0px;"><span id="txt11_5878612b" class="nokern relpos" style="left:7.2px;top:69.805px;"></span><span id="txt12_5878612b" class="relpos" data-width="627.750000" style="left:25.965px;top:69.392px;">The GOAL Program is evaluating the management of patients at high-risk, defined as those with</span></div><div style="width:0px;"><span id="txt13_5878612b" data-width="656.806641" style="left:34.2px;top:90.992px;">clinical atherosclerotic cardiovascular disease, and an LDL-C &gt;2.0 mmol/L despite maximal tolerated</span></div><div style="width:0px;"><span id="txt14_5878612b" data-width="88.628906" style="left:34.2px;top:112.592px;">statin therapy</span></div></div><div id="spr7_5878612b" style="left:4.821px;top:118.893px;"><div style="width:0px;"><span id="txt15_5878612b" class="nokern relpos" style="left:7.2px;top:156.205px;"></span><span id="txt16_5878612b" class="relpos" data-width="657.263672" style="left:25.965px;top:155.792px;">The program incorporates a mechanism to support decision making and choice of therapy in order to</span></div><div style="width:0px;"><span id="txt17_5878612b" data-width="649.001953" style="left:34.2px;top:177.392px;">assist physicians in achieving the Canadian Cardiovascular Society guideline-recommended LDL-C</span></div><div style="width:0px;"><span id="txt18_5878612b" data-width="179.709961" style="left:34.2px;top:198.992px;">targets in high risk patients.</span></div></div><div id="spr8_5878612b" style="left:4.821px;top:118.893px;"><div style="width:0px;"><span id="txt19_5878612b" data-width="363.366211" style="left:7.2px;top:242.036px;">The interactive program has 3 distinct components:</span></div></div><div id="spr9_5878612b" style="left:4.821px;top:118.893px;"><div style="width:0px;"><span id="txt20_5878612b" class="nokern relpos" data-width="10.945313" style="left:43.2px;top:280.343px;">1.</span><span id="txt21_5878612b" class="relpos" data-width="587.679688" style="left:59.255px;top:280.343px;">Capture of data as reported by the physician based on LDL-C lowering strategies at each visit.</span></div></div><div id="spr10_5878612b" style="left:4.821px;top:118.893px;"><div style="width:0px;"><span id="txt22_5878612b" class="nokern relpos" data-width="10.945313" style="left:43.2px;top:299.543px;">2.</span><span id="txt23_5878612b" class="relpos" data-width="512.500000" style="left:59.255px;top:299.543px;">Feedback on potential opportunities for LDL-C lowering based on CCS guidelines.</span></div></div><div id="spr11_5878612b" style="left:4.821px;top:118.893px;"><div style="width:0px;"><span id="txt24_5878612b" class="nokern relpos" data-width="10.945313" style="left:43.2px;top:318.743px;">3.</span><span id="txt25_5878612b" class="relpos" data-width="570.187500" style="left:59.255px;top:318.743px;">Identification of challenges and reasons faced by physicians (continuation of the care gap).</span></div></div><div id="spr12_5878612b" style="left:12.156px;top:502.021px;"><img id="img3_5878612b" src="data/img13.png" width="67" height="30" alt="" style="left:1.987px;top:4.107px;"/></div></div></div>');})();